Malignant immunoproliferative disease: Difference between revisions
Ttenbergen (talk | contribs) No edit summary |
|||
| (17 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{ICD10 transition status | {{ICD10 transition status | ||
| OldDxArticle =Waldenstrom's Macroglobulinemia| CurrentStatus = | | OldDxArticle =Waldenstrom's Macroglobulinemia| CurrentStatus = reconciled | ||
| InitialEditorAssigned = Debbie Page-Newton | | InitialEditorAssigned = Debbie Page-Newton | ||
}} | }} | ||
{{ICD10 dx | {{ICD10 dx | ||
| MinimumCombinedCodes = | |||
| ICD10 Code=C88 | | ICD10 Code=C88 | ||
| BugRequired= | | BugRequired= | ||
}} | }} | ||
{{ICD10 category|Heme/immunology}}{{ICD10 category|Neoplastic}} | |||
== Additional Info == | == Additional Info == | ||
'''Includes''' | |||
* Waldenstrom's macroglobulinemia (bone marrow disorder) | |||
*Immunoproliferative disorders | |||
**Immunoproliferative disorders, also known as immunoproliferative diseases or immunoproliferative neoplasms, are disorders of the immune system that are characterized by the abnormal proliferation of the primary cells of the immune system, which includes B cells, T cells and natural killer (NK) cells, or by the excessive production of immunoglobulins (also known as antibodies). | |||
**These disorders are subdivided into three main classes, which are lymphoproliferative disorders, hypergammaglobulinemia, and paraproteinemia. | |||
{{ICD10 Guideline Cancer}} | |||
== Alternate ICD10s to consider coding instead or in addition == | |||
== Candidate [[Combined ICD10 codes]] == | == Candidate [[Combined ICD10 codes]] == | ||
== Related CCI Codes == | |||
{{Data Integrity Check List}} | |||
== Related Articles == | == Related Articles == | ||
{{Related Articles}} | {{Related Articles}} | ||
{{ICD10 footer}} | |||
{{EndPlaceHolder}} | |||